ML390 is a human DHODH inhibitor that induces differentiation in acute myeloid leukemia.ML390 was active with an ED50 (effective concentration triggering 50% of its maximal differentiation activity) of 2 M in murine and human AML cell lines, offering insight into the mechanism of overcoming differentiation arrest. DHODH inhibitors demonstrated effective at prolonging survival in animal models of leukemia
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | ML390 |
| Iupac 化学名称 | ML390 |
| 同义词 | N/A |
| 英文同义词 | N/A |
| 分子式 | C21H21F3N2O3 |
| 分子量 | 406.4 |
| Smile | C[Si](C)(C)CSCCl |
| InChiKey | IKWIERSJEROYFH-UHFFFAOYSA-N |
| InChi | InChI=1S/C5H13ClSSi/c1-8(2,3)5-7-4-6/h4-5H2,1-3H3 |
| Cas号 | 2029049-79-2 |
| MDL | MFCD17013410 |
| 相关CAS号 | |
| 外观性状 | crystalline solid |
| 纯度 | 98% |
| 存储 | 3 years -20ºCpowder |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |